YieldMax MRNA Option Income Strategy ETF
MRNY
6 hedge funds and large institutions have $26.5M invested in YieldMax MRNA Option Income Strategy ETF in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
134% more capital invested
Capital invested by funds: $11.4M → $26.5M (+$15.2M)
100% more funds holding
Funds holding: 3 → 6 (+3)
0.37% less ownership
Funds ownership: 4.78% → 4.41% (-0.37%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
+$22.7M |
| 2 |
Jane Street
New York
|
+$393K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$193K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$185K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$1.25K |
Top Sellers
MRNY Hedge Fund Activity: Q4 2024 in Review
6 of the 7,601 institutional investors tracked by Wall St. Rank reported a position in YieldMax MRNA Option Income Strategy ETF (MRNY) for Q4 2024, worth a combined $26.5M — up 134% from $11.4M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MRNY positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Tidal Investments, adding an estimated $22.7M.
- 6 institutional investors held YieldMax MRNA Option Income Strategy ETF (MRNY) as of Q4 2024, up from 3 in Q3 2024.
- Funds reported $26.5M of YieldMax MRNA Option Income Strategy ETF stock for Q4 2024, up 134% quarter-over-quarter.
- 3 funds opened new YieldMax MRNA Option Income Strategy ETF positions in Q4 2024 and 0 closed out, a net change of +3 holders.
- The largest YieldMax MRNA Option Income Strategy ETF buyer in Q4 2024 was Tidal Investments, an estimated $22.7M added.
Based on aggregated 13F filings for Q4 2024.